Display options
Share it on

Front Oncol. 2012 Dec 03;2:168. doi: 10.3389/fonc.2012.00168. eCollection 2012.

Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers.

Frontiers in oncology

Susan Pyne, Joanne Edwards, Jan Ohotski, Nigel J Pyne

Affiliations

  1. Cell Biology Group, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde Glasgow, UK.

PMID: 23316473 PMCID: PMC3540928 DOI: 10.3389/fonc.2012.00168

Abstract

There is substantial evidence for a role in cancer of the bioactive lipid sphingosine 1-phosphate (S1P), the enzyme sphingosine kinase 1 (that catalyses S1P formation) and S1P-specific G protein-coupled receptors. This perspective highlights recent findings demonstrating that sphingosine kinase 1 and S1P receptors are new important biomarkers for detection of early cancer and progression to aggressive cancer. The impact of the sub-cellular distribution of S1P metabolizing enzymes and S1P receptors and their spatial functional interaction with oncogenes is considered with respect to prognostic outcome. These findings suggest that S1P, in addition to being a biomarker of clinical prognosis, might also be a new therapeutic target for intervention in cancer.

Keywords: disease-specific survival; estrogen receptor; recurrence; sphingosine 1-phosphate; triple negative breast cancer

References

  1. Curr Biol. 2000 Nov 30;10(23):1527-30 - PubMed
  2. Mol Cancer. 2006 Dec 08;5:69 - PubMed
  3. Mol Cancer Res. 2011 Nov;9(11):1509-19 - PubMed
  4. Int J Cancer. 2013 Feb 1;132(3):605-16 - PubMed
  5. Int J Hematol. 2008 Apr;87(3):266-75 - PubMed
  6. J Neurosci. 2011 May 4;31(18):6850-7 - PubMed
  7. J Exp Med. 2005 Jan 3;201(1):49-54 - PubMed
  8. J Neuropathol Exp Neurol. 2005 Aug;64(8):695-705 - PubMed
  9. Breast Cancer Res Treat. 2008 Nov;112(1):41-52 - PubMed
  10. J Biol Chem. 2010 Dec 10;285(50):38841-52 - PubMed
  11. Cell. 2011 Mar 4;144(5):646-74 - PubMed
  12. Br J Cancer. 2012 Apr 10;106(8):1453-9 - PubMed
  13. J Biol Chem. 2007 Apr 13;282(15):10922-34 - PubMed
  14. Am J Pathol. 2010 Nov;177(5):2205-15 - PubMed
  15. Biochem Biophys Res Commun. 2006 Apr 21;342(4):1284-90 - PubMed
  16. Oncogene. 2012 Mar 1;31(9):1166-75 - PubMed
  17. Br J Cancer. 2012 Feb 28;106(5):909-15 - PubMed
  18. FASEB J. 2009 Feb;23(2):405-14 - PubMed
  19. Science. 2009 Sep 4;325(5945):1254-7 - PubMed
  20. Exp Hematol. 2011 Jun;39(6):653-665.e6 - PubMed
  21. Mol Cancer Res. 2005 May;3(5):287-96 - PubMed
  22. Cell Cycle. 2007 Mar 1;6(5):522-7 - PubMed
  23. Nat Rev Cancer. 2010 Jul;10(7):489-503 - PubMed
  24. Nature. 2010 Jun 24;465(7301):1084-8 - PubMed
  25. Biochem J. 2006 Aug 15;398(1):55-62 - PubMed
  26. FASEB J. 2011 Feb;25(2):600-12 - PubMed
  27. Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17384-9 - PubMed
  28. Mol Cell Biol. 2010 Aug;30(15):3827-41 - PubMed
  29. J Surg Res. 2006 Jan;130(1):80-7 - PubMed
  30. Mol Cell Biol. 2006 Oct;26(19):7211-23 - PubMed
  31. Cell Signal. 2010 Oct;22(10):1536-42 - PubMed

Publication Types